Show an ad over header. AMP

I am the FIRST!!!

Pfizer raises COVID-19 vaccine sales estimate by 29% to $33.5 billion

Pfizer expects revenue from the COVID-19 vaccine, co-developed by BioNTech, will reach $33.5 billion this year — a 29% jump from the previously estimated $26 billion.

Why it matters: This vaccine, which has dramatically slowed the coronavirus pandemic, is on pace to be the world's top-selling drug of all time, by far. And now Pfizer is pushing for people to get a third "booster" shot of its vaccine to combat the growing Delta variant.


By the numbers: Pfizer registered $7.8 billion of COVID-19 vaccine sales in the second quarter, bringing total worldwide sales so far this year to $11.3 billion.

  • Pfizer expects to deliver 2.1 billion doses this year and has the capacity to manufacture 4 billion doses next year, CEO Albert Bourla said on a conference call.
  • The U.S. previously paid $19.50 per dose for the Pfizer-BioNTech vaccine, but Pfizer recently raised the price to the government to $24 per dose.
  • Flashback: Last year, Bourla said the company would not put a "huge price" on the vaccine, "because that's really taking advantage of a situation, and people will not forget if you do that."

Driving the news: Pfizer said it has new data showing a third dose of its vaccine increases antibody levels significantly against the Delta variant.

  • Pfizer has a financial interest in people, especially Americans, getting a third dose, as it would grow revenues even more.
  • However, epidemiologists have pointed out that higher antibody levels do not mean higher protection, and Pfizer's two-dose schedule is already effective against the coronavirus, including the Delta variant.

The big picture: A majority of the Pfizer-BioNTech vaccine has gone to wealthy countries, whose governments pay higher prices for drugs than lower-income countries.

  • Many lower-income countries have started demanding more doses as their coronavirus cases, hospitalizations and deaths rise.
  • "Africa was largely spared by the pandemic in 2020, but not this year. We lack vaccines, and we are gasping for air," Mosoka Fallah, former director-general of the National Public Health Institute of Liberia, said this week.

What to watch: Moderna reports vaccine sales and earnings Aug. 5.

  • Johnson & Johnson said it expects its COVID-19 vaccine will generate $2.5 billion of sales this year.

regular 4 post ff

infinite scroll 4 pff

Advocates turn attention on bugs, birds, fish, and plants with racists names

Bugs, birds, fish and plants with names linked to white supremacists may be renamed, as science confronts its own ties to systemic racism.

Why it matters: The national reckoning was inevitably going to pass this way. The sciences have long underrepresented and erected barriers of entry to people of color and there’s a concerted effort for a reset under way in academia, research and hiring.

Keep reading...Show less

Movements on Mars unlock the Red Planet's interior

Seismic action on Mars is revealing new details about the inner structure of the Red Planet.

Why it matters: Mars' interior holds the key to understanding how the planet and its atmosphere formed — and provides clues about how other rocky planets, like Earth, become habitable.

Keep reading...Show less

Tucker Carlson sought interview with Putin at time of NSA spying claim

Tucker Carlson was talking to U.S.-based Kremlin intermediaries about setting up an interview with Vladimir Putin shortly before the Fox News host accused the National Security Agency of spying on him, sources familiar with the conversations tell Axios.

Why it matters: Those sources said U.S. government officials learned about Carlson's efforts to secure the Putin interview. Carlson learned that the government was aware of his outreach — and that's the basis of his extraordinary accusation, followed by a rare public denial by the NSA that he had been targeted.

Keep reading...Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;